Several genes showing enhanced THC sensitivity across development, notably pyramidal-enriched Pacsin1 [58], as well as Clu [59] and Snap25 [60], are also implicated in psychiatric diseases such as schizophrenia and mood disorders. The gene discussed is SNAP25; the disease is mood disorder.